ONKURE, INC.

Profile

Company Names

ONKURE, INC.

Addresses

6707 WINCHESTER CIRCLE, SUITE 400, BOULDER, CO 80301

1105 SPRUCE STREET, BOULDER, CO 80302

2106 ANDREW ALDEN STREET, LONGMONT, CO 80504

1067 S. HOVER STREET, UNIT E; PMB# 204, LONGMONT, CO 80501

Phone Numbers

720 307 2892
720 323 9110

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$123,181,625.00

Number of Funding Rounds:

10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2023-03-24 
$53,783,369.00 
$60,000,000.00 
$6,216,631.00 
Equity 
9
2021-03-03 
$56,649,181.00 
$56,649,181.00 
$0.00 
Equity 
8
2020-08-04 
$1,500,000.00 
$2,000,000.00 
$500,000.00 
Debt 
7
2020-04-15 
$3,236,935.00 
$5,236,935.00 
$2,000,000.00 
Equity 
6
2020-03-04 
$1,000,000.00 
$2,000,000.00 
$1,000,000.00 
Debt 
5
2019-09-20 
$100,000.00 
$2,000,000.00 
$1,900,000.00 
Debt 
4
2018-02-06 
$4,957,450.00 
$4,957,450.00 
$0.00 
Equity 
3
2015-06-26 
$855,000.00 
$1,000,000.00 
$145,000.00 
Debt 
2
2013-06-04 
$599,705.00 
$599,705.00 
$0.00 
Equity 
1
2011-10-20 
$499,985.00 
$499,985.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHEAL 
 
CARRUTHERS 
DIRECTOR
ONKURE, INC.
R. 
MICHAEL 
CARRUTHERS 
DIRECTOR
ARRAY BIOPHARMA INC   |  ONKURE, INC.   |  ONKURE THERAPEUTICS, INC.
JOHN 
 
DEMATTEI 
EXECUTIVE OFFICER
ONKURE, INC.
ZHAO 
 
GUABAO 
DIRECTOR
ONKURE, INC.
ZHAO 
 
GUOBAO 
DIRECTOR
ONKURE, INC.
JASON 
 
LEVERONE 
EXECUTIVE OFFICER
MIRAGEN THERAPEUTICS INC   |  ONKURE, INC.   |  ONKURE THERAPEUTICS, INC.
XUEDONG 
 
LIU 
EXECUTIVE OFFICER, DIRECTOR
ONKURE, INC.   |  VESICLE THERAPEUTICS INC.
ISAAC 
 
MANKE 
DIRECTOR
ONKURE, INC.   |  ADDEX THERAPEUTICS LTD.   |  ONKURE THERAPEUTICS, INC.
KEITH 
M. 
OLIVIA 
EXECUTIVE OFFICER
ONKURE, INC.
KEITH 
MICHAEL 
OLIVIA 
EXECUTIVE OFFICER
ONKURE, INC.
DONNA 
 
PEAK 
EXECUTIVE OFFICER, DIRECTOR
ONKURE, INC.   |  VESICLE THERAPEUTICS INC.
KEN 
 
PEAK 
EXECUTIVE OFFICER, DIRECTOR
ONKURE, INC.
ANDREW 
J. 
PHILLIPS 
DIRECTOR
ONKURE, INC.
ANTHONY 
D. 
PISCOPIO 
EXECUTIVE OFFICER, DIRECTOR
ONKURE, INC.
JOSEPH 
 
ROMANO 
DIRECTOR
ONKURE, INC.
NICHOLAS 
 
SACCOMANO 
DIRECTOR
ONKURE, INC.   |  BIOLOOMICS, INC.   |  ONKURE THERAPEUTICS, INC.   |  MODULO BIO, INC.   |  KESTREL THERAPEUTICS INC.
DUNCAN 
 
WALKER 
EXECUTIVE OFFICER
INVESCO U.S. INCOME REIT, LLC   |  IREF IV REIT, LLC   |  ICRE REIT HOLDINGS   |  RUNWAY SUB REIT, LLC   |  INVESCO U.S. INCOME MASSACHUSETTS REIT HOLDINGS, LLC   |  INVESCO CORE REAL ESTATE - U.S.A., L.P.   |  INVESCO U.S. INCOME FUND, L.P.   |  INVESCO COMMERCIAL MORTGAGE INCOME FUND, L.P.   |  CLO CMI BLOCKER, LLC   |  CLO CMI FEEDER, L.P.   |  CRYSTAL REIT INVESTORS, LLC   |  INVESCO COMMERCIAL MORTGAGE INCOME - U.S. FUND, L.P.   |  INVESCO REAL ESTATE U.S. FUND VI, L.P.   |  ONKURE, INC.   |  PRETIUM MILE HIGH REIT (CORE), LLC   |  PRETIUM MILE HIGH REIT (INCOME), LLC   |  PRETIUM MILE HIGH REIT (VALUE), LLC   |  IRE U.S. FUND VI FEEDER, L.P.   |  IRE U.S. FUND VI EMPLOYEE FEEDER, L.P.   |  IRE U.S. FUND VI BLOCKER, LLC   |  SSC VENTURE PARTNERS IV LP
JAMES 
 
WINKLER 
EXECUTIVE OFFICER
DMI LIFE SCIENCES, INC.   |  ONKURE, INC.
GUOBAO 
 
ZHAO 
DIRECTOR
ONKURE, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-04-03
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2023-03-24 
2022-03-04
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-03 
2021-03-05
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-03 
2020-09-30
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2020-08-04 
2020-08-06
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2020-08-04 
2020-04-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-04-15 
2020-03-06
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2020-03-04 
2019-09-20
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2019-09-20 
2018-02-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-02-06 
2017-06-08
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-06-26 
2015-07-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-06-26 
2013-06-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-04 
2013-04-09
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2011-10-20 
2011-10-31
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2011-10-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
SOLEBURY CAPITAL LLC
143299